Thota, R.; Yang, M.; Pflieger, L.; Schell, M.J.; Rajan, M.; Davis, T.B.; Wang, H.; Presson, A.; Pledger, W.J.; Yeatman, T.J.
APC and TP53 Mutations Predict Cetuximab Sensitivity across Consensus Molecular Subtypes. Cancers 2021, 13, 5394.
https://doi.org/10.3390/cancers13215394
AMA Style
Thota R, Yang M, Pflieger L, Schell MJ, Rajan M, Davis TB, Wang H, Presson A, Pledger WJ, Yeatman TJ.
APC and TP53 Mutations Predict Cetuximab Sensitivity across Consensus Molecular Subtypes. Cancers. 2021; 13(21):5394.
https://doi.org/10.3390/cancers13215394
Chicago/Turabian Style
Thota, Ramya, Mingli Yang, Lance Pflieger, Michael J. Schell, Malini Rajan, Thomas B. Davis, Heiman Wang, Angela Presson, Warren Jack Pledger, and Timothy J. Yeatman.
2021. "APC and TP53 Mutations Predict Cetuximab Sensitivity across Consensus Molecular Subtypes" Cancers 13, no. 21: 5394.
https://doi.org/10.3390/cancers13215394
APA Style
Thota, R., Yang, M., Pflieger, L., Schell, M. J., Rajan, M., Davis, T. B., Wang, H., Presson, A., Pledger, W. J., & Yeatman, T. J.
(2021). APC and TP53 Mutations Predict Cetuximab Sensitivity across Consensus Molecular Subtypes. Cancers, 13(21), 5394.
https://doi.org/10.3390/cancers13215394